Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMID 20851216)

Published in Clin Gastroenterol Hepatol on September 17, 2010

Authors

Mee Joo Kang1, Jin-Young Jang, Soo Jin Kim, Kyoung Bun Lee, Ji Kon Ryu, Yong-Tae Kim, Yong Bum Yoon, Sun-Whe Kim

Author Affiliations

1: Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.

Articles citing this

The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res (2014) 1.32

Pancreatico-biliary endoscopic ultrasound: a systematic review of the levels of evidence, performance and outcomes. World J Gastroenterol (2012) 0.99

Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Ann Surg (2016) 0.99

Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions. Gut Liver (2015) 0.97

Intraductal Papillary Mucinous Neoplasm of Pancreas. N Am J Med Sci (2015) 0.97

International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas. Ann Transl Med (2015) 0.88

Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings. Eur Radiol (2014) 0.84

Therapeutic Approach to Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am (2016) 0.84

Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN. Oncol Lett (2013) 0.81

Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy. Dig Dis Sci (2015) 0.81

Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. Ann Surg (2015) 0.80

Early detection of pancreatic cancer. Chin J Cancer Res (2015) 0.80

Risk factors for malignancy in branched-type intraductal papillary mucinous neoplasms of the pancreas during the follow-up period. World J Surg (2015) 0.79

Endoscopic retrograde pancreatography: When should we do it? World J Gastrointest Endosc (2015) 0.79

Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management. Am J Gastroenterol (2017) 0.79

Pancreatic Cysts and Guidelines. Dig Dis Sci (2017) 0.78

Comparison of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging for Pancreas Cystic Lesions. Medicine (Baltimore) (2015) 0.77

What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses. Clin Transl Gastroenterol (2015) 0.77

Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts. BMC Gastroenterol (2012) 0.77

IPMN: surgical treatment. Langenbecks Arch Surg (2013) 0.77

Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography. World J Gastroenterol (2015) 0.76

Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up. Med Sci Monit (2017) 0.75

Cystic lesions of the pancreas. Ann Gastroenterol (2016) 0.75

Contrast-enhanced ultrasound of pancreatic tumours. Australas J Ultrasound Med (2015) 0.75

Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions. J Investig Med (2016) 0.75

Long-term outcome of cystic lesions in the pancreas: a retrospective cohort study. Gut Liver (2012) 0.75

MDCT evaluation of the growth kinetics of serous and benign mucinous cystic neoplasms of the pancreas. Cancer Imaging (2011) 0.75

Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms. World J Gastroenterol (2014) 0.75

Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions. Endosc Ultrasound (2016) 0.75

MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm. Mol Clin Oncol (2016) 0.75

Familial Pancreatic Cancer and the Future of Directed Screening. Gut Liver (2017) 0.75

Editorial: Stopping Pancreatic Cyst Surveillance? Am J Gastroenterol (2017) 0.75

Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct. World J Surg (2015) 0.75

Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. J Gastrointest Surg (2017) 0.75

Articles by these authors

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology (2012) 7.22

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27

Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc (2008) 3.43

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol (2010) 2.18

Recruitment of dynein to the Jurkat immunological synapse. Proc Natl Acad Sci U S A (2006) 2.15

Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma. World J Surg (2013) 2.05

Small (<or=3 cm) solid pseudopapillary tumors of the pancreas at multiphasic multidetector CT. Radiology (2010) 2.04

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther (2009) 2.01

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One (2010) 1.96

Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol (2005) 1.95

A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc (2006) 1.90

Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer. Ann Surg (2009) 1.85

Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology (2011) 1.84

TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.84

High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg (2006) 1.78

Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas (2006) 1.72

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas (2008) 1.67

Rha1, an Arabidopsis Rab5 homolog, plays a critical role in the vacuolar trafficking of soluble cargo proteins. Plant Cell (2003) 1.67

TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66

EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc (2007) 1.59

Attenuation-based automatic tube voltage selection and tube current modulation for dose reduction at contrast-enhanced liver CT. Radiology (2012) 1.59

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58

Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.49

Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer. BMC Genomics (2015) 1.44

Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.43

Clinical characteristics and prognostic factors of primary pulmonary vein stenosis or atresia in children. Ann Thorac Surg (2012) 1.42

[Natural history of branch-duct type intraductal papillary mucinous neoplasms of the pancreas]. Korean J Gastroenterol (2007) 1.41

Does endoscopic sphincterotomy reduce the recurrence rate of cholangitis in patients with cholangitis and suspected of a common bile duct stone not detected by ERCP? Gastrointest Endosc (2007) 1.40

TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.39

Management of postoperative hemorrhage after pancreatoduodenectomy. Hepatogastroenterology (2003) 1.39

US-guided fine-needle aspiration of thyroid nodules: indications, techniques, results. Radiographics (2008) 1.38

Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg (2005) 1.37

Comment on "Deformation of biological cells in the acoustic field of an oscillating bubble". Phys Rev E Stat Nonlin Soft Matter Phys (2010) 1.37

Identification of the protein storage vacuole and protein targeting to the vacuole in leaf cells of three plant species. Plant Physiol (2004) 1.36

Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg (2011) 1.33

Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy. J Am Coll Surg (2003) 1.32

Interobserver agreement in assessing the sonographic and elastographic features of malignant thyroid nodules. AJR Am J Roentgenol (2009) 1.32

Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients. Atherosclerosis (2008) 1.28

A case of gangliocytic paraganglioma in the ampulla of Vater. World J Surg Oncol (2010) 1.27

Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg (2005) 1.26

Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol (2007) 1.24

Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology (2011) 1.23

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients. Diabetes Care (2008) 1.22

Phospholipase A(2) is required for PIN-FORMED protein trafficking to the plasma membrane in the Arabidopsis root. Plant Cell (2010) 1.21

Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol (2011) 1.21

Clinical features and outcome of solid pseudopapillary neoplasm: differences between adults and children. Arch Surg (2008) 1.20

Actin filaments play a critical role in vacuolar trafficking at the Golgi complex in plant cells. Plant Cell (2005) 1.20

Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology (2006) 1.20

Metastasis to the gallbladder: a single-center experience of 20 cases in South Korea. World J Gastroenterol (2009) 1.19

Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol (2009) 1.17

Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol (2007) 1.16

Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology (2013) 1.15

Risk factors for recurrent cholangitis after initial hepatolithiasis treatment. J Clin Gastroenterol (2004) 1.14

A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc (2009) 1.14

Normal structure, variations, and anomalies of the pancreaticobiliary ducts of Koreans: a nationwide cooperative prospective study. Gastrointest Endosc (2002) 1.14

Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol (2011) 1.13

Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg (2010) 1.13

Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. AJR Am J Roentgenol (2010) 1.12

Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc (2012) 1.12

A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg (2014) 1.12

MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging (2011) 1.11

Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics (2002) 1.10

Survival and prognostic factors of unresectable pancreatic cancer. J Clin Gastroenterol (2008) 1.10